Diabetic Neuropathy, Painful Completed Phase 3 Trials for Duloxetine (DB00476)

IndicationStatusPhase
DBCOND0030279 (Diabetic Neuropathy, Painful)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00058968A Study for the Treatment of Painful Diabetic NeuropathyTreatment
NCT01089556A Study in Painful Diabetic NeuropathyTreatment
NCT01179672A Study in Participants With Diabetic Peripheral Neuropathic Pain in ChinaTreatment